Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
Clinical trial NCT03023384 · UNKNOWN
Trial details
- NCT number
- NCT03023384
- Sponsor
- International Consortium on Acute Leukemias
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-01
- Primary completion
- 2021-01-01
- Enrollment
- 547
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.